35 min
Talking Techniques| Hans Keirstead on precision therapeutics for cancer and science in politics Future Science Group
-
- Science
Hans Kierstead, CEO and founder of Aivita Biomedical, Speaks to Tristan Free, Digital Editor of BioTechniqes. Hans delves into his company's exciting new precision immunotherapy, currently undergoing phase II trials and discusses his 2018 run for US Congress, explaining why he is passionate about the need for scientists in politics.
Hans Kierstead, CEO and founder of Aivita Biomedical, Speaks to Tristan Free, Digital Editor of BioTechniqes. Hans delves into his company's exciting new precision immunotherapy, currently undergoing phase II trials and discusses his 2018 run for US Congress, explaining why he is passionate about the need for scientists in politics.
35 min